Multiple myeloma (MM) is a plasma cell disorder characterized by clonal proliferation of malignant plasma cells producing monoclonal proteins and causing organ damage. The involvement of the kidney in MM and other plasma cell dyscrasias is widespread. At the time of presentation, about 50% of the patients could have involvement of the kidney, and it is associated with higher mortality.